The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Artificial Heart Valve Market Research Report 2024
Synopsis
An artificial heart valve is a device implanted into the heart of a patient to replace a dysfunctional native heart valve (valvular heart disease).
The global Artificial Heart Valve market was valued at US$ 8876 million in 2023 and is anticipated to reach US$ 18630 million by 2030, witnessing a CAGR of 11.2% during the forecast period 2024-2030.
Artificial heart valves are medical devices designed to replace damaged or diseased natural heart valves, restoring normal blood flow and improving cardiac function. Several factors are driving the growth of the artificial heart valve market. Firstly, the increasing prevalence of cardiovascular diseases, such as valvular heart disease, is contributing to the rising demand for artificial heart valves. The aging population, sedentary lifestyles, and unhealthy dietary habits have led to a higher incidence of heart valve disorders, creating a significant patient population in need of valve replacement. Secondly, technological advancements in heart valve technologies have significantly improved the performance and durability of artificial valves. The development of bioprosthetic valves, mechanical valves, and transcatheter heart valves has enhanced treatment options and provided better outcomes for patients. These advancements have also led to the minimally invasive implantation of heart valves, reducing the risks associated with traditional open-heart surgeries.
This report aims to provide a comprehensive presentation of the global market for Artificial Heart Valve, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Heart Valve.
Report Scope
The Artificial Heart Valve market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Heart Valve market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Heart Valve manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Edwards Lifesciences
Medtronic
Abbott
Boston Scientific Corporation
LivaNova
Symetis
Jenavalve Technology
Cryolife
TTK Healthcare Limited
Colibri Heart Valve
Lepu Medical Technology
Braile Biomédica
Micro Interventional
Segment by Type
Transcatheter Heart Valves
Tissue Heart Valves
Mechanical Heart Valves
Segment by Application
Hospital
Clinic
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Artificial Heart Valve manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Artificial Heart Valve in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
An artificial heart valve is a device implanted into the heart of a patient to replace a dysfunctional native heart valve (valvular heart disease).
The global Artificial Heart Valve market was valued at US$ 8876 million in 2023 and is anticipated to reach US$ 18630 million by 2030, witnessing a CAGR of 11.2% during the forecast period 2024-2030.
Artificial heart valves are medical devices designed to replace damaged or diseased natural heart valves, restoring normal blood flow and improving cardiac function. Several factors are driving the growth of the artificial heart valve market. Firstly, the increasing prevalence of cardiovascular diseases, such as valvular heart disease, is contributing to the rising demand for artificial heart valves. The aging population, sedentary lifestyles, and unhealthy dietary habits have led to a higher incidence of heart valve disorders, creating a significant patient population in need of valve replacement. Secondly, technological advancements in heart valve technologies have significantly improved the performance and durability of artificial valves. The development of bioprosthetic valves, mechanical valves, and transcatheter heart valves has enhanced treatment options and provided better outcomes for patients. These advancements have also led to the minimally invasive implantation of heart valves, reducing the risks associated with traditional open-heart surgeries.
This report aims to provide a comprehensive presentation of the global market for Artificial Heart Valve, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Heart Valve.
Report Scope
The Artificial Heart Valve market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Heart Valve market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Heart Valve manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Edwards Lifesciences
Medtronic
Abbott
Boston Scientific Corporation
LivaNova
Symetis
Jenavalve Technology
Cryolife
TTK Healthcare Limited
Colibri Heart Valve
Lepu Medical Technology
Braile Biomédica
Micro Interventional
Segment by Type
Transcatheter Heart Valves
Tissue Heart Valves
Mechanical Heart Valves
Segment by Application
Hospital
Clinic
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Artificial Heart Valve manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Artificial Heart Valve in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Artificial Heart Valve Market Overview
1.1 Product Overview and Scope of Artificial Heart Valve
1.2 Artificial Heart Valve Segment by Type
1.2.1 Global Artificial Heart Valve Market Value Comparison by Type (2024-2030)
1.2.2 Transcatheter Heart Valves
1.2.3 Tissue Heart Valves
1.2.4 Mechanical Heart Valves
1.3 Artificial Heart Valve Segment by Application
1.3.1 Global Artificial Heart Valve Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Artificial Heart Valve Market Size Estimates and Forecasts
1.4.1 Global Artificial Heart Valve Revenue 2019-2030
1.4.2 Global Artificial Heart Valve Sales 2019-2030
1.4.3 Global Artificial Heart Valve Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Artificial Heart Valve Market Competition by Manufacturers
2.1 Global Artificial Heart Valve Sales Market Share by Manufacturers (2019-2024)
2.2 Global Artificial Heart Valve Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Artificial Heart Valve Average Price by Manufacturers (2019-2024)
2.4 Global Artificial Heart Valve Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Artificial Heart Valve, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Artificial Heart Valve, Product Type & Application
2.7 Artificial Heart Valve Market Competitive Situation and Trends
2.7.1 Artificial Heart Valve Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Artificial Heart Valve Players Market Share by Revenue
2.7.3 Global Artificial Heart Valve Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Artificial Heart Valve Retrospective Market Scenario by Region
3.1 Global Artificial Heart Valve Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Artificial Heart Valve Global Artificial Heart Valve Sales by Region: 2019-2030
3.2.1 Global Artificial Heart Valve Sales by Region: 2019-2024
3.2.2 Global Artificial Heart Valve Sales by Region: 2025-2030
3.3 Global Artificial Heart Valve Global Artificial Heart Valve Revenue by Region: 2019-2030
3.3.1 Global Artificial Heart Valve Revenue by Region: 2019-2024
3.3.2 Global Artificial Heart Valve Revenue by Region: 2025-2030
3.4 North America Artificial Heart Valve Market Facts & Figures by Country
3.4.1 North America Artificial Heart Valve Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Artificial Heart Valve Sales by Country (2019-2030)
3.4.3 North America Artificial Heart Valve Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Artificial Heart Valve Market Facts & Figures by Country
3.5.1 Europe Artificial Heart Valve Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Artificial Heart Valve Sales by Country (2019-2030)
3.5.3 Europe Artificial Heart Valve Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Artificial Heart Valve Market Facts & Figures by Country
3.6.1 Asia Pacific Artificial Heart Valve Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Artificial Heart Valve Sales by Country (2019-2030)
3.6.3 Asia Pacific Artificial Heart Valve Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Artificial Heart Valve Market Facts & Figures by Country
3.7.1 Latin America Artificial Heart Valve Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Artificial Heart Valve Sales by Country (2019-2030)
3.7.3 Latin America Artificial Heart Valve Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Artificial Heart Valve Market Facts & Figures by Country
3.8.1 Middle East and Africa Artificial Heart Valve Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Artificial Heart Valve Sales by Country (2019-2030)
3.8.3 Middle East and Africa Artificial Heart Valve Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Artificial Heart Valve Sales by Type (2019-2030)
4.1.1 Global Artificial Heart Valve Sales by Type (2019-2024)
4.1.2 Global Artificial Heart Valve Sales by Type (2025-2030)
4.1.3 Global Artificial Heart Valve Sales Market Share by Type (2019-2030)
4.2 Global Artificial Heart Valve Revenue by Type (2019-2030)
4.2.1 Global Artificial Heart Valve Revenue by Type (2019-2024)
4.2.2 Global Artificial Heart Valve Revenue by Type (2025-2030)
4.2.3 Global Artificial Heart Valve Revenue Market Share by Type (2019-2030)
4.3 Global Artificial Heart Valve Price by Type (2019-2030)
5 Segment by Application
5.1 Global Artificial Heart Valve Sales by Application (2019-2030)
5.1.1 Global Artificial Heart Valve Sales by Application (2019-2024)
5.1.2 Global Artificial Heart Valve Sales by Application (2025-2030)
5.1.3 Global Artificial Heart Valve Sales Market Share by Application (2019-2030)
5.2 Global Artificial Heart Valve Revenue by Application (2019-2030)
5.2.1 Global Artificial Heart Valve Revenue by Application (2019-2024)
5.2.2 Global Artificial Heart Valve Revenue by Application (2025-2030)
5.2.3 Global Artificial Heart Valve Revenue Market Share by Application (2019-2030)
5.3 Global Artificial Heart Valve Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Edwards Lifesciences
6.1.1 Edwards Lifesciences Corporation Information
6.1.2 Edwards Lifesciences Description and Business Overview
6.1.3 Edwards Lifesciences Artificial Heart Valve Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Edwards Lifesciences Artificial Heart Valve Product Portfolio
6.1.5 Edwards Lifesciences Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Corporation Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Artificial Heart Valve Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Medtronic Artificial Heart Valve Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Artificial Heart Valve Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Abbott Artificial Heart Valve Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 Boston Scientific Corporation
6.4.1 Boston Scientific Corporation Corporation Information
6.4.2 Boston Scientific Corporation Description and Business Overview
6.4.3 Boston Scientific Corporation Artificial Heart Valve Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Boston Scientific Corporation Artificial Heart Valve Product Portfolio
6.4.5 Boston Scientific Corporation Recent Developments/Updates
6.5 LivaNova
6.5.1 LivaNova Corporation Information
6.5.2 LivaNova Description and Business Overview
6.5.3 LivaNova Artificial Heart Valve Sales, Revenue and Gross Margin (2019-2024)
6.5.4 LivaNova Artificial Heart Valve Product Portfolio
6.5.5 LivaNova Recent Developments/Updates
6.6 Symetis
6.6.1 Symetis Corporation Information
6.6.2 Symetis Description and Business Overview
6.6.3 Symetis Artificial Heart Valve Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Symetis Artificial Heart Valve Product Portfolio
6.6.5 Symetis Recent Developments/Updates
6.7 Jenavalve Technology
6.6.1 Jenavalve Technology Corporation Information
6.6.2 Jenavalve Technology Description and Business Overview
6.6.3 Jenavalve Technology Artificial Heart Valve Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Jenavalve Technology Artificial Heart Valve Product Portfolio
6.7.5 Jenavalve Technology Recent Developments/Updates
6.8 Cryolife
6.8.1 Cryolife Corporation Information
6.8.2 Cryolife Description and Business Overview
6.8.3 Cryolife Artificial Heart Valve Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Cryolife Artificial Heart Valve Product Portfolio
6.8.5 Cryolife Recent Developments/Updates
6.9 TTK Healthcare Limited
6.9.1 TTK Healthcare Limited Corporation Information
6.9.2 TTK Healthcare Limited Description and Business Overview
6.9.3 TTK Healthcare Limited Artificial Heart Valve Sales, Revenue and Gross Margin (2019-2024)
6.9.4 TTK Healthcare Limited Artificial Heart Valve Product Portfolio
6.9.5 TTK Healthcare Limited Recent Developments/Updates
6.10 Colibri Heart Valve
6.10.1 Colibri Heart Valve Corporation Information
6.10.2 Colibri Heart Valve Description and Business Overview
6.10.3 Colibri Heart Valve Artificial Heart Valve Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Colibri Heart Valve Artificial Heart Valve Product Portfolio
6.10.5 Colibri Heart Valve Recent Developments/Updates
6.11 Lepu Medical Technology
6.11.1 Lepu Medical Technology Corporation Information
6.11.2 Lepu Medical Technology Artificial Heart Valve Description and Business Overview
6.11.3 Lepu Medical Technology Artificial Heart Valve Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Lepu Medical Technology Artificial Heart Valve Product Portfolio
6.11.5 Lepu Medical Technology Recent Developments/Updates
6.12 Braile Biomédica
6.12.1 Braile Biomédica Corporation Information
6.12.2 Braile Biomédica Artificial Heart Valve Description and Business Overview
6.12.3 Braile Biomédica Artificial Heart Valve Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Braile Biomédica Artificial Heart Valve Product Portfolio
6.12.5 Braile Biomédica Recent Developments/Updates
6.13 Micro Interventional
6.13.1 Micro Interventional Corporation Information
6.13.2 Micro Interventional Artificial Heart Valve Description and Business Overview
6.13.3 Micro Interventional Artificial Heart Valve Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Micro Interventional Artificial Heart Valve Product Portfolio
6.13.5 Micro Interventional Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Artificial Heart Valve Industry Chain Analysis
7.2 Artificial Heart Valve Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Artificial Heart Valve Production Mode & Process
7.4 Artificial Heart Valve Sales and Marketing
7.4.1 Artificial Heart Valve Sales Channels
7.4.2 Artificial Heart Valve Distributors
7.5 Artificial Heart Valve Customers
8 Artificial Heart Valve Market Dynamics
8.1 Artificial Heart Valve Industry Trends
8.2 Artificial Heart Valve Market Drivers
8.3 Artificial Heart Valve Market Challenges
8.4 Artificial Heart Valve Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
